FOR IMMEDIATE RELEASE
Contact: Audrey Ann Ross
Statement from AccessMatters’ President & CEO Melissa Weiler Gerber On SCOTUS Action to Allow Continued Access to Mifepristone
[PHILADELPHIA, PA – April 21, 2023]: This evening, the Supreme Court of the United States issued a stay that maintains current access to mifepristone, a medicine commonly used in medication abortion and miscarriage management. The Court stayed the ruling by the Texas district court in, Alliance for Hippocratic Medicine v. FDA which sought to block the FDA’s approval of mifepristone.
Following tonight’s decision, AccessMatters released the following statement from Melissa Weiler Gerber:
“Tonight, the ruling by the highest court in our nation serves to maintain status quo for people to access mifepristone across our country during a tenuous and uncertain time for access to abortion care. While we are grateful for the outcome of tonight’s ruling and applaud the Supreme Court for taking swift action, we remain deeply concerned about the right to abortion care in the United States being left to the political whim of individual states. It is clear that access to abortion care remains uncertain and continuously under attack in our nation.
As a public health organization, AccessMatters will continue to support access to abortion care – both abortion procedures and medication abortion – and access to all reproductive health options. This is our message tonight to people across the Commonwealth and the nation: Abortion remains legal and mifepristone remains legal and accessible.
We remain hopeful that abortion access will prevail throughout the appeals process, and we remain committed to ensuring people have access to all reproductive health options, allowing them to make the best decision for themselves and their own future.”
– Melissa Weiler Gerber, President & CEO
AccessMatters’ mission is to protect, expand, and enhance equitable access to sexual and reproductive health care and information for all people. For more information about AccessMatters’ programs, follow @AccessMatters4U on Twitter, and @AccessMatters on Facebook.